Table 1.

Clinical and Pathological Features and Cytogenetic Analyses of Primary RMS Cases.

RMS Number	Age at Biopsy (years)/Sex	Primary Site/LNM	Stage at Presentation Intergroup Rhabdomyosarcoma Study	Outcome until December 2005	Karyotype Descriptions
ERMS1	1/F	Arm	Group 1, stage 1	NED	46,XX,+2,-8,der(17)t(11;17)(q13;p13),der(19)t(19;8)(q13.4;?),der(22) t(19;22)(?;q13)t(8;19)(q?11.2;?)[6]/47,idem,+7[7]/48,idem,+7,+9[1]/46,XX[2]*
ERMS2	7/M	Leg and thigh/LNM	Group 2, stage 1	D	46, Complex karyotype†
ARMS1	1/M	Bilateral groins/LNM	Group 3	D	83∼85,XXYY,+i(1)(q10),t(2;12)(p?14;q23)x2,i(3)(q10),der(3)del(p24)t(3;17) (q13;?),der(4)t(4;11)(p12;?)x2,der(5)t(5;12)(q12;?)x2,der(8)t(4;8)(?;p12), -9,-9,+der(10)t(2;10)(?;p?),-11,del(12)(q13q21)x2,del(13)(q14)x2,-15, -15,del(17)(q22),-17,-21,2 dmin (3)[cp17]/46,XY[5]*
ARMS2	2/F	Arm	Group 1, stage 1	NED	92,XXXX,10∼30 dmin (13)[7]/46,XX[10]*
ARMS3	3/M	Perineum	Group 2, stage 1	D	46,XY[15]†
ARMS4	17/F	Hand	Group 1, stage 1	NED	46,XX[25]†
ARMS5	18/M	Thigh/LNM	Group 1, stage 1	D	92,XXYY,del(13)(q14)x2,der(20)t(13;20)(q14;q13.3)x2,10†30 dmin (13)[12]/46,XY[5]*
ARMS6	24/M	Groin/LNM	Group 2, stage 1	D	100∼104<4n>,XXXYYY,+2,-3,+5,+6,+6,+7,+8,+8,+8,+8,-9,+10,-11, -11,+12,+12,+12,-17,-19,-19,+20,+22,+22,+22,20∼30 dmin (1)[10]/46,XY[5]*
ARMS7	31/F	Perineum/LNM	Group 2, stage 1	D	46,XX[15]†
PRMS1	68/M	Groin/LNM	Group 2, stage 1	D	74∼82,XXY,del(1)(p11)x2+idic(1)(q10),del(2)(p1?6)x2,del(3)(q13)x2,-4, der(4)t(4;16)(p11;p11),der(4)t(4;17)(q28;q11),del(5)(p13), +der(5)t(5;6)(q?35;?),der(5)t(5;10)(q3?4;q?21),del(6)(p?12),+i(6) (q10),+der(6)t(6;6)(q2?5;q?),der(7)t(6;7),der(7)del(7)(p21)del(7)(q31), +der(8)t(8;8)(p23;q22)x2,+der(8)t(4;8)(?;q11),der(9)t(9;20)(q13;q11.2), +der(9)t(9;20)(q13;q11.2),der(10)t(5;10)(?;p11)x2,+der(10)ins(5) dup(10)(q22),+del(11)(q2?1),+der(11)t(3;11)(?;q21),-13,-14,+15,+der(15) t(15;16)(p10;p10)x2,-16,der(17)t(17;22)(p12;q12)x2,+der(17)del(17) (q11)t(11;17)(?;p13),-18,+18,-19,+der(19)del(19)(p13)del(19)(q13),-20, del(20)(q11),-21,+22,+22,+22,+del(22)(q12)[cp12]*

LNM, lymph node metastasis found; NED, no evidence of disease; D, died.

^*G-banding and SKY analyses.

^†G-banding analysis.